ABSTRACT. Medium-chain triglycerides, with a chain length of eight and 10 carbon atoms, form up to 50% of the total fat content in some preterm infant formulas. In 20 small preterm infants (birthwt: 1153 f 227 g; mean 2 SD) fed a special formula containing 40% MCT, a primed constant oral infusion study of l-'3C-potassium octanoate was conducted to quantify the oxidation of MCT. A plateau in 13C enrichment in breath COz was reached in all patients within 1-3 h. Simultaneously, substrate utilization was measured using a closed system indirect calorimeter. No significant difference was found between appropriate for gestational age (n = 8) and small for gestational age (n = 12) infants in the percentage of the administered tracer that was oxidized (44.9 f 9
Vco2, carbon dioxide production Voz, oxygen consumption
The optimal composition of the oral feeding solution for a preterm infant remains a matter of debate. Milk from mothers who delivered preterm, although containing more protein and minerals than milk from mothers who delivered at term, may not be sufficient to prevent deficiencies or to produce wt gain equivalent to the intrauterine growth curve (1, 2) . The various formulas specially designed for preterm infants differ considerReceived December 16, 1988 ; accepted May 17, 1989 . Correspondence and reprint requests to Prof. Dr. P. J. J. Sauer ably, reflecting unanswered questions regarding the optimal composition of such formulas.
Some preterm infant formulas contain up to 50% of the fat as MCT, intended to enhance fat absorption and to provide a readily available energy source. Improved wt gain and retention of fat, protein, and calcium have been described with MCTcontaining formulas (3, 4) . No reliable data exist regarding the percentage of orally administered MCT that is oxidized by the preterm infant. The objectives of this study were to quantify octanoic acid oxidation as an indication of MCT oxidation and to measure utilization of other substrates in preterm infants receiving a formula containing 40% of fat as MCT.
MATERIALS AND METHODS

Subjects.
Infants with a birthwt of <I600 g were included in the study after they were on full oral feedings, gaining wt, and clinically stable breathing room air. Twenty patients entered the study, eight patients AGA, group I, and 12 patients SGA, group 11.
AGA was defined as a birthwt within 2 SD of the mean for gestation, according to the growth curves of Usher and McLean (5) . SGA was defined as a birthwt more than 2 SD below the mean. Gestational age was determined by medical history and Ballard score (6) . All infants were initially admitted to the Neonatal Intensive Care unit of the Academic Hospital Rotterdam/Sophia Children's Hospital, five in group I and six in group I1 had been ventilated for the respiratory distress syndrome in the neonatal period. Mean body wt, gestational age, and age at the time of study are shown in Table 1 .
Feeding regimen. All infants received a formula (Nenatal, Nutricia, Zoetermeer, the Netherlands) in which 40% of the fat is provided as MCT, from the day oral feedings started, usually at day 7. The composition of the formula is given in Table 2 . In our ward verv low birth wt infants routinelv are fed bv continuous nasogastric gavage. Infants were studied i t least 3'd after they had reached the maximum intake of 150 mL/kg/d of the formula. During the studies, the gavage feeding was administered using a syringe pump (Perfusor Secura FT, Braun, Melsungen, FRG). study procedure. The study protocol was approved by the Human Subject Review Committee of the Academic Hospital Rotterdam and Erasmus University. Written informed consent was obtained from the parents. The study design was as follows. In the 4th postnatal wk urine was collected for 72 h. In the middle of this collection period, indirect calorimetry was performed for a 6-to 8-h period. During indirect calorimetry, a primed constant infusion of 1-13C potassium octanoate was given.
Indirect calorimetry. Metabolic rate and substrate utilization were measured by a closed circuit indirect calorimeter. Continuous measurements were performed for 6-8 h, as previously described (7) . Briefly, an air mixture devoid of carbon dioxide enters the incubator. In a sample of the air leaving the incubator the C02 concentration is measured, whereafter all carbon dioxide is filtered out by a soda-lime filter. The C02 is injected again into the airflow by a mass flow injector system until the same concentration of C 0 2 is measured by the infrared meter (Unor 6N, Maihak, Hamburg, FRG). The amount of carbon dioxide injected into the system equals the carbon dioxide production of the infant. Thereafter all C 0 2 is filtered by a second filter. The amount of oxygen consumed by the infant is equal to the amount of oxygen that has to be injected into the system to keep the oxygen tension constant, as measured by polarographic oxygen cells (type 622377 1 Beckman Instruments, Fullerton, CA) in the system and in a reference vessel. To compensate for changes in air-pressure, the reference vessel is connected to the flow circuit by means of a capillary. Oxygen consumption and carbon dioxide production are measured with an accuracy of 0.2 mL/min, the RQ during calibration with butane was within 2% of the theoretical value. Urine was collected in plastic bags over a period of 3 d. Urinary nitrogen concentration of a pooled sample was determined by combustion in an automatic nitrogen analyzer (ANA 1400; Carlo Erba, Milano, Italy) by the Dumas procedure (8) .
Measurement of octanoate oxidation. Octanoic acid oxidation was measured using l-'3C-potassium octanoate. The labeled octanoic acid (99% purity, Sigma Chemical Co., St. Louis, MO) was converted into its potassium salt by means of titration with KOH in our laboratory and diluted in sterile water. To determine the natural background of I3C, three baseline breath samples were collected during 15 min each before starting the isotope infusion. The bicarbonate pool was then primed with 6.9 pmol. kg-' of a 6.9 mM solution of NaH13C03 (80% purity, Merck Isotopes, Montreal, Canada) as previously described (9) . At the same time, a 1 -'3C-octanoate priming dose of 2 mg/kg was given, followed by a constant infusion of 2 mg/kg/h for 6-8h. All isotopes were administered through a separate nasogastric tube. The delivery rate of the pump during the study was measured by dividing the difference in weight of the syringe before and after the experiment by the duration of the experiment to determine the actual quantity of l-13C-octanoate administered. Once the isotope infusion was started, 15 min CO2 breath collections were made every hour for 4 h, and every 30 min for 2-4 more h. Breath C 0 2 was collected by passing a sample of the air leaving the incubator through an all glass spiral condensor, containing 10 mL of a fresh 1 M NaOH solution. Samples were transferred to Vacutainers and stored at -20°C until analysis. Trapping of C 0 2 was shown to be complete during 15 min at a flow of approximately 10 mL/min and hence isotopic fractionation was prevented. In a study conducted without the administration of isotopes, a shift in natural background over time was ruled out, as could be expected during a continuous feeding regime.
Isotopic ratio mass spectrometric analysis. Respiratory carbon dioxide was liberated at torr by adding 85% phosphoric acid to the NaHC03 solution. Pure C 0 2 was collected in a small glass container in liquid nitrogen whereas the water was trapped in a methanol dry ice bath. The glass container with pure CO2 was connected to a VG Sira 10 isotope ratio mass spectrometer (Vacuum Generators, Winsford, Cheshire, UK). Results of I3C abundance of both baseline and plateau were calculated as APE/ reference C 0 2 tank standard sample. Isotopic plateau was defined by eyeballing as the absence of a change in abundance with time.
Calculations. The percentage of I3CO2 recovery was calculated as follows. 1 ) 13C02 production (gmol . kg-'. h .-I) = VC02 = carbon dioxide production (STPD) in mL. kg-'. min-'; H = plateau height I3CO2 above baseline in APE; C = correction factor for l3CO2 retention in the bicarbonate pool, calculated from the energy intake of the infant (9).
2) 13C administered (gmol . kg-' . h-') = 1-13C octanoate (pmol . 4) The percentage I3C recovery was considered to be equal to the percentage of the tracer that was oxidized.
5) Nonprotein V02 and nonprotein VC02 were derived from V02 and VC02 by correcting the values for the protein oxidation, calculated as 6.25 x the timed urinary nitrogen-excretion. 6) Metabolic rate and partition of the non-protein macronutrients were calculated from nonprotein RQ and nonprotein V02 using the tables of Lusk (10).
7) Statistical analysis of the differences between the results of the two groups was conducted using the Mann-Whitney U test.
RESULTS
The energy and substrate intake of the infants is shown in Table 3 . There were no differences in intake between SGA and AGA infants. The results of indirect calorimetry are shown in Table 4 . The metabolic rate was significantly higher in the SGA (12, 13) . Orally administered MCT are absorbed mainly as free fatty acids, because their intraluminal hydrolysis is rapid and almost complete. Recently it was shown that marked hydrolysis occurs in the stomach of the preterm neonate and that a significant part of octanoate acid is absorbed directly in the stomach (14) . MCT can also be absorbed in part as triglycerides (15) . In most cases a total of more than 99% are absorbed (3, 16, 17) . If absorption as a triglyceride takes place, hydrolysis by an intestinal lipase will follow within the enterocyte (15) . Unlike LCT, the MCFA derived from MCT are not reesterified, so all MCT will leave the intestinal cells as MCFA and reach the liver via the portal vein as free fatty acids in solution in plasma or bound to albumin (18) .
To study the metabolism of MCT, sodium-13C-octanoate has been used as a tracer in adults (19) . Octanoate can be regarded as a tracer representative of trioctanoin metabolism, considering the fact that both the free fatty acid and triglyceride with a chain length of eight carbons will enter at one stage the free fatty acid pool in the intestinal cells.
MCT have been included in preterm infant formulas because of their high rate of absorption. They are also referred to as a readily available source of energy, implying a rapid and almost complete oxidation of MCT (15, 20, 21) . Even the existence of an obligatory oxidation of MCFA with increased heat production has been suggested (22, 23) . In this study, we found that in both AGA and SGA infants an average of no more than 47% of the administered octanoate was oxidized, with a range of 32 to 64%.
In a study using the bolus technique and I3C labeled trioctanoin as a tracer in a small number of preterm infants, a cumulative oxidation of 27% of the tracer was found (24) . Recent studies showed that MCT might have a tendency to adhere to the feeding tube, due to its hydrophobic properties (25) . If part of the trioctanoin used as a tracer adheres to tubing during the experiment, this can give falsely low results on recovery of the tracer. By using the water-soluble potassium salt of octanoic acid we minimized the risk that tracer would adhere to the tubing. This might explain the fact that we found a higher oxidation rate, although the bolus technique is not fully comparable to the constant infusion technique. When discussing the physiologic significance of our findings we will have to consider the further steps in the metabolic pathways followed by MCT.
In the liver, MCFA readily cross the membrane into the reach statistical significance. The production of I3C02 in breath rose in the 1st h in all patients and a plateau was reached in all patients within 1-3 h. An example of a characteristic study is
shown in Figure 1 . The results of the isotopic studies are shown . .
in Table 5 . These results show a I3CO2 recovery for AGA and mitochondria, where they are activated and broken down into acetyl-CoA. This acetyl-CoA can enter the tricarboxylic acid cycle and, under the conditions of our study, will be detected as labeled C02 after oxidation. When there is excess acetyl-CoA, a major pathway is formation of ketone bodies; in fact, MCFA are known to be ketogenic (26) . Feeding of an MCT-containing formula for 4 d promotes a mild ketosis in preterm infants (27) . These ketone bodies will be quickly utilized peripherally, especially after a period of adaptation (28) . Because the conversion to ketones is a rapid process (29) , most of the excreted I3CO2 due to the oxidation of ketone bodies derived from MCT will also contribute to the 13C enrichment in expired air, thus being included in our calculation. One of the conditions that have to be fulfilled to make this assumption is that the pool of ketones remains constant, which means that the concentration of ketone bodies in the plasma should not change during the experiment. We think this was the case during these studies, because these infants were on the same intake of the MCT formula for at least 3 d before starting the study, and were in a clinical stable condition. Hence, there is no reason to assume that in the groups studied an increase in the ketone body pool during the experiment could have been responsible for retention of the label.
We conclude that both ways of immediate oxidative disposal of MCFA, entering the Krebs cycle directly or via the formation of ketone bodies, are included in the values for oxidation of MCT we found in this study. Following this line of reasoning, about half of the MCT in this feeding regimen follows other OXIDATION OF MCT BY PRETERM INFANTS 297 pathways than oxidation. Urinary loss of dicarboxylic acids that can exist during MCT feeding probably accounts for less than 1 % of the dietary intake of MCT in preterm infants (30) .
Furthermore, MCFA are not to a significant amount activated by coenzyme A in the extramitochondrial space to participate directly in triglyceride and phospholipid synthesis (3 1). Accordingly, storage of octanoate as a triglyceride in adipose tissue does not seem to be of great importance (32) (33) (34) . Apparently, MCFA have to be converted into long-chain fatty acids before they can be stored as LCT in the body fat tissue. Probably the most important route quantitatively for this is the breakdown of MCT into acetyl-CoA, whereafter LCT is formed through de novo lipogenesis (35) .
The relatively low oxidation rate we found is consistent with the findings that breakdown of MCFA and lipogenesis occur sequentially during MCT feeding (36) . The oxidation rates we found might indicate that in these patients lipogenesis is an important pathway for MCT, whereas fitting less well with the assumption of an obligatory oxidation as a cause of the enhanced thermogenesis that is sometimes encountered on a MCT diet (22, 23) . If we assume a mean absorption of 85% of the LCT in these patients ( I 6, 17), MCT would account for around 45 % of the absorbed fatty acids. Combining the mean value for total fat oxidation we obtained by indirect calorimetry with results from the isotopic studies, we find that oxidation of MCT accounts for 65% of the fat oxidation in SGA and 85% in AGA infants. Apparently there is a preferential oxidation of MCT, but whether this aspect of MCT metabolism is advantageous remains to be proven.
Remarkably, although SGA infants have a significantly higher metabolic rate, we found no increase in the MCT oxidation, suggesting there might be a limit to the amount of MCT that can be completely oxidized by the small preterm infant.
